Viewing StudyNCT00254735



Ignite Creation Date: 2024-05-05 @ 12:08 PM
Last Modification Date: 2024-10-26 @ 9:21 AM
Study NCT ID: NCT00254735
Status: COMPLETED
Last Update Posted: 2007-12-18
First Post: 2005-11-15

Brief Title: Quetiapine Augmentation in Severe Obsessive Compulsive Disorder
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
Obsessive Compulsive Disorder
Keywords:
Name View
Obsessive Compulsive Disorder OCD View